Latest / Decera Clinical Education Oncology Podcast
Precision Therapy in Lung Cancer: FAQ on Biomarker Testing and Targeted Therapies
In this episode, Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer questions focused on biomarker testing and selecting targeted therapy for patients with advanced non-small-cell lung cancer with topics including:
How to approach discordant results with liquid vs tissue biopsies
Repeating NGS testing at progression
Selecting urgent treatment when molecular results are not yet available
Point mutations in NTRK fusion–positive disease
Selecting second-line therapy for EGFR-positive disease with high PD-L1 expression after first-line TKI
Selecting first-line and second-line therapy…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.